Kutsch, Nadine, Fink, Anna Maria and Fischer, Kirsten (2022). Management of front line chronic lymphocytic leukemia. Am. J. Hematol., 97. S. S3 - 8. HOBOKEN: WILEY. ISSN 1096-8652
Full text not available from this repository.Abstract
Treatment options with targeted agents have changed the treatment landscape of CLL profoundly. Besides chemoimmunotherapy, treatment regimen approved for frontline therapy include continuous treatment with BTK inhibitors like ibrutinib and acalabrutinib or fixed-duration regimen like venetoclax-obinutuzumab with the approval of venetoclax-ibrutinib to be awaited. Although these agents have usually manageable side effects, toxicities might limit choices for the individual patient. We here discuss latest trial data and propose a treatment algorithm for frontline treatment of CLL according to fitness and relevant genetic risk factors like IGHV mutational status and TP53 aberrations.
Item Type: | Journal Article | ||||||||||||||||
Creators: |
|
||||||||||||||||
URN: | urn:nbn:de:hbz:38-661475 | ||||||||||||||||
DOI: | 10.1002/ajh.26677 | ||||||||||||||||
Journal or Publication Title: | Am. J. Hematol. | ||||||||||||||||
Volume: | 97 | ||||||||||||||||
Page Range: | S. S3 - 8 | ||||||||||||||||
Date: | 2022 | ||||||||||||||||
Publisher: | WILEY | ||||||||||||||||
Place of Publication: | HOBOKEN | ||||||||||||||||
ISSN: | 1096-8652 | ||||||||||||||||
Language: | English | ||||||||||||||||
Faculty: | Unspecified | ||||||||||||||||
Divisions: | Unspecified | ||||||||||||||||
Subjects: | no entry | ||||||||||||||||
Uncontrolled Keywords: |
|
||||||||||||||||
URI: | http://kups.ub.uni-koeln.de/id/eprint/66147 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
View Item |